Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Prior

Showing results (261-270 of 292) with videos related to

Pageof 30
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 15, 2001
Muscularity and the density of the fat-free mass in athletesB M Prior, C M Modlesky, E M Evans, et al.
European Journal of Applied Physiology|June 29, 2004
MRI evaluation of topical heat and static stretching as therapeutic modalities for the treatment of eccentric exercise-induced muscle damageR C Jayaraman, R W Reid, J M Foley, et al.
ACS Chemical Biology|June 12, 2019
Small-Molecule Inhibition of the <i>C. difficile</i> FAS-II Enzyme, FabK, Results in Selective ActivityJesse A Jones, Allan M Prior, Ravi K R Marreddy, et al.
Life Sciences|July 19, 2001
Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial diseaseE Arosio, P Minuz, M Prior, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1972
The effect of heparin and dipyridamole on chronic vascular lesions in monkey cardiac allograftsD R Kahn, J H Dufek, H A Oberman, et al.
Disease Markers|June 1, 1986
Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritisM C Sweatman, J R Markwick, P J Charles, et al.
The Annals of Thoracic Surgery|July 1, 1971
Treatment of bronchogenic carcinoma with mediastinal metastasesM M Kirsh, D R Kahn, O Gago, et al.
ACS Infectious Diseases|December 4, 2018
The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile InfectionRavi K R Marreddy, Xiaoqian Wu, Madhab Sapkota, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2009
Translocation experiments with butterflies reveal limits to enhancement of poleward populations under climate changeShannon L Pelini, Jason D K Dzurisin, Kirsten M Prior, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2014
Inhibition of long chain fatty acyl-CoA synthetase (ACSL) and ischemia reperfusion injuryAllan M Prior, Man Zhang, Nina Blakeman, et al.
Pageof 30

Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 15, 2001
Muscularity and the density of the fat-free mass in athletesB M Prior, C M Modlesky, E M Evans, et al.
European Journal of Applied Physiology|June 29, 2004
MRI evaluation of topical heat and static stretching as therapeutic modalities for the treatment of eccentric exercise-induced muscle damageR C Jayaraman, R W Reid, J M Foley, et al.
ACS Chemical Biology|June 12, 2019
Small-Molecule Inhibition of the <i>C. difficile</i> FAS-II Enzyme, FabK, Results in Selective ActivityJesse A Jones, Allan M Prior, Ravi K R Marreddy, et al.
Life Sciences|July 19, 2001
Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial diseaseE Arosio, P Minuz, M Prior, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1972
The effect of heparin and dipyridamole on chronic vascular lesions in monkey cardiac allograftsD R Kahn, J H Dufek, H A Oberman, et al.
Disease Markers|June 1, 1986
Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritisM C Sweatman, J R Markwick, P J Charles, et al.
The Annals of Thoracic Surgery|July 1, 1971
Treatment of bronchogenic carcinoma with mediastinal metastasesM M Kirsh, D R Kahn, O Gago, et al.
ACS Infectious Diseases|December 4, 2018
The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile InfectionRavi K R Marreddy, Xiaoqian Wu, Madhab Sapkota, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2009
Translocation experiments with butterflies reveal limits to enhancement of poleward populations under climate changeShannon L Pelini, Jason D K Dzurisin, Kirsten M Prior, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2014
Inhibition of long chain fatty acyl-CoA synthetase (ACSL) and ischemia reperfusion injuryAllan M Prior, Man Zhang, Nina Blakeman, et al.
Pageof 30